部分再プログラムによる年齢に関連する特徴の改善
Alejandro Ocampo1, Pradeep Reddy1, Paloma Martinez-Redondo1
1Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Cell
|December 17, 2016
まとめ
ヤマナカ因子 (Oct4,Sox2,Klf4,c-Myc) を使った部分的な再プログラムにより,老化の特徴が逆転し,寿命が延び,健康状態が改善されました. この研究は in vivo の再プログラミングを証明しています
科学分野:
- ゲロントロジー
- エピジェネティクス
- 細胞生物学
背景:
- 老化は多くの人間の病気の主な危険因子です.
- 細胞を再プログラムすることで 細胞の老化を逆転させることが 実験で示されています
- 老化過程に対する再プログラム効果のインビボの証拠は限られている.
研究 の 目的:
- 細胞の部分的な再プログラムが 老化に及ぼすインビボ効果を調査する.
- OSKMの短期的な周期的発現が老化特性を改善し,寿命を延ばすことができるかどうかを判断する.
- 年齢に関連する生理学的衰退に対する in vivo 再プログラミングの影響を評価する.
主な方法:
- 早期老化のマウスモデルにおけるOct4,Sox2,Klf4,c-Myc (OSKM) の周期的発現を用いた部分的な再プログラム.
- 細胞と生理学的老化の特徴の評価
- 治療されたマウスの寿命延長の評価
- 代謝疾患と筋肉損傷からの回復を評価するために,老いた野生型のマウスの体内OSKM発現.
主要な成果:
- OSKMの短期的な発現は,老化の細胞的および生理的特徴をマウスで改善した.
- 早期老化のマウスモデルにおける 部分的な再プログラムにより寿命が延びた
- 老いた野生型のマウスの体内でのOSKM発現は,代謝疾患と筋肉損傷からの回復を改善した.
結論:
- 哺乳類の高齢化の主な要因です
- 生体内での部分的再プログラミングは,表遺伝的改造によって,年齢に関連する表型を逆転させることができます.
- エピジェネティックマークを調節する インビボプラットフォームの開発は 老化生物学を理解するために不可欠です
関連する概念動画
Somatic to iPS Cell Reprogramming
2.8K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.8K
Methods of Nuclear Reprogramming
2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
Introduction to Nuclear Reprogramming
2.4K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.4K
iPS Cell Differentiation
3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K
Chromatin Modification in iPS Cells
2.3K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.3K


